{
    "clinical_study": {
        "@rank": "138095", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to make cancer cells stop dividing\n      so they stop growing or die. Combining chemotherapy with corticosteroids may be an effective\n      treatment for prostate cancer.\n\n      PURPOSE: Randomized phase III trial to compare the effectiveness of methylprednisolone with\n      or without doxorubicin in treating patients who have metastatic prostate cancer that has not\n      responded to hormone therapy."
        }, 
        "brief_title": "Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer", 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Determine the effect of weekly doxorubicin on the quality of life of patients\n      with metastatic, hormone-refractory, symptomatic prostate cancer. II. Determine the\n      contribution of this treatment on control of pain in these patients. III. Determine the\n      toxicity of this regimen in these patients. IV. Determine the objective response and\n      biological observations in these patients after this treatment. V. Determine the effect of\n      this regimen on survival of these patients.\n\n      OUTLINE: This is a randomized, multicenter study. Patients are randomized to one of two\n      treatment arms. Arm I: Patients receive methylprednisolone IV weekly for 3 months. Arm II:\n      Patients receive methylprednisolone IV and doxorubicin IV weekly for 3 months. Quality of\n      life is assessed before treatment, every 4 weeks during treatment, and then every 3 months.\n      Patients are followed every 3 months.\n\n      PROJECTED ACCRUAL: A total of 160 patients will be accrued for this study within 3 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically proven, symptomatic prostate cancer Appearance or\n        aggravation of clinical symptoms with progression of disease Bone pain OR Urethral\n        compression OR 20% decrease in performance status Metastatic disease Local-regional or\n        distant secondary tumors Documented radiologically or scintigraphically Hormone-refractory\n        as defined by progression while on hormone treatment (simple castration or complete\n        androgen blockage) Progressive disease No urethral or cervical stenosis Increase of\n        greater than 25% prostatic volume on endorectal echography No documentation by PSA\n        increase or imagery only Hormone castration verified by testosterone less than 0.5 ng/mL\n        No history of CNS metastases\n\n        PATIENT CHARACTERISTICS: Age: Over 18 Performance status: Karnofsky 60-100% Life\n        expectancy: No specified Hematopoietic: Neutrophil count greater than 1500/mm3 Platelet\n        count greater than 100,000/mm3 Hemoglobin greater than 9 g/dL Hepatic: Bilirubin less than\n        1.5 times normal Renal: Creatinine less than 1.6 mg/dL Cardiovascular: Ventricular\n        ejection fraction at least 50% Other: No contraindication to anthracycline treatment No\n        prior primary cancer except basal cell skin cancer\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior\n        chemotherapy Arm I: No concurrent chemotherapy Endocrine therapy: At least 1 month since\n        prior hormone therapy, including estramustine, except LHRH agonists, which continue Arm I:\n        No concurrent estramustine Radiotherapy: At least 3 months since prior strontium 89 No\n        concurrent strontium Surgery: See Disease Characteristics"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003682", 
            "org_study_id": "CDR0000066784", 
            "secondary_id": [
                "FRE-FNCLCC-GETUG-02", 
                "EU-98058"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "methylprednisolone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Doxorubicin", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Methylprednisolone", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "keyword": [
            "stage IV prostate cancer", 
            "recurrent prostate cancer"
        ], 
        "lastchanged_date": "July 23, 2008", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/FRE-FNCLCC-GETUG-02"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Avignon", 
                        "country": "France", 
                        "zip": "84082"
                    }, 
                    "name": "Institut Sainte Catherine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21079"
                    }, 
                    "name": "Centre de Lute Contre le Cancer,Georges-Francois Leclerc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69373"
                    }, 
                    "name": "Centre Leon Berard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13273"
                    }, 
                    "name": "Institut J. Paoli and I. Calmettes"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34298"
                    }, 
                    "name": "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes-Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "CRLCC Nantes - Atlantique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06189"
                    }, 
                    "name": "Centre Antoine Lacassagne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nimes", 
                        "country": "France", 
                        "zip": "30006"
                    }, 
                    "name": "C.H.U. - Hopital Gaston Doumergue"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75181"
                    }, 
                    "name": "Hotel Dieu de Paris"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Institut Mutualiste Montsouris"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51056"
                    }, 
                    "name": "Institut Jean Godinot"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35064"
                    }, 
                    "name": "Centre Eugene Marquis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76038"
                    }, 
                    "name": "Centre Henri Becquerel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Cloud", 
                        "country": "France", 
                        "zip": "92211"
                    }, 
                    "name": "Centre Rene Huguenin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Nazaire", 
                        "country": "France", 
                        "zip": "44600"
                    }, 
                    "name": "Centre Hospitalier General de Saint Nazaire"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "official_title": "Treatment of Metastatic Prostate Cancer That is Hormone-Independent: Evaluation of the Role of Chemotherapy on the Quality of Life of Patients. Phase II Study", 
        "overall_official": {
            "affiliation": "Centre Val d'Aurelle - Paul Lamarque", 
            "last_name": "Stephane Culine, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003682"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNICANCER", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 1998", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2007"
    }, 
    "geocoordinates": {
        "C.H.U. - Hopital Gaston Doumergue": "43.837 4.36", 
        "CRLCC Nantes - Atlantique": "47.21 -1.602", 
        "Centre Antoine Lacassagne": "43.696 7.266", 
        "Centre Eugene Marquis": "48.113 -1.676", 
        "Centre Henri Becquerel": "49.443 1.1", 
        "Centre Hospitalier General de Saint Nazaire": "47.273 -2.214", 
        "Centre Leon Berard": "45.764 4.836", 
        "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle": "43.611 3.877", 
        "Centre Rene Huguenin": "48.848 2.208", 
        "Centre de Lute Contre le Cancer,Georges-Francois Leclerc": "47.322 5.041", 
        "Hotel Dieu de Paris": "48.857 2.352", 
        "Institut J. Paoli and I. Calmettes": "43.296 5.37", 
        "Institut Jean Godinot": "49.258 4.032", 
        "Institut Mutualiste Montsouris": "48.857 2.352", 
        "Institut Sainte Catherine": "43.949 4.806"
    }
}